Açık Akademik Arşiv Sistemi

Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?

Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?

Ağaç, Mustafa Tarık; Ağaç, Mustafa Tarık; Behlul Kahyaoglu; Muhammed Murat Necati Aksoy; Cinemre, Fatma Behice; Vatan, Mehmet Bülent; Gündüz, Yasemin
URI: https://doi.org/10.14744/AnatolJCardiol.2018.25564
https://hdl.handle.net/20.500.12619/66123
Date: 2019

Abstract:

Conclusion: Endocan may not serve as a useful biomarker at asymptomatic vascular stages of hypertension, despite its role in indicating disease severity and inflammatory activation in advanced symptomatic CV and renal disease.

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess